Morning Break: Heroin Deadlier than Guns; Abilify Fines; Interstate Insurance Flops


Morning Break: Heroin Deadlier than Guns; Abilify Fines; Interstate Insurance Flops insurance

For the first time, heroin deaths surpass gun homicides in the U.S. It’s even worse factoring in fentanyl and other synthetics. ()

Finally, Endo International sold the rights to an opioid back to BioDelivery Services International, as that market has received more scrutiny. ()

Bristol-Meyers Squibb will pay $19.5 million for off-label marketing of Abilify. The antipsychotic was marketed for use in children and Alzheimer’s patients. ()

More than a third of Medicaid expansion enrollees were smokers. As a result, many have more tools to quit, Salynn Boyles reports.

Elsevier launched a new index, CiteScore, that grades the quality of academic journals. ()

Interstate insurance sales have been getting a lot of praise. But in Georgia, where lawmakers passed a bill in 2011 allowing insurance companies to sell products from other states, there still aren’t any takers. ()

The CDC’s Heads Up program started 13 years ago to raise concussion awareness, but plenty of work remains. Ryan Basen explores: is the program a flop?

A coalition of interest groups plans to fight the ACA repeal. ()

Long stretches of sitting can undo those occasional trips to the gym. ()

The medical device tax, suspended since last January, looks to become permanent under the Trump administration. (Reuters)

More Zika complications emerge — it may impact vision and cause hearing loss. ()

And in New York City, at least five babies have been born with Zika-related brain development symptoms. ()

We’re in the midst of a mumps outbreak. More than 3,800 cases so far — nearly triple last year’s number. ()

As life expectancy takes a slight hit in the U.S., WHO reports that it’s up in several countries with high HIV burdens. ()